Big pharma's interest in using protein degradation as a therapeutic strategy continues with a wide-ranging deal between Pfizer and US biotech Triana Biomedicines that could be worth $1.5 billion or ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

This plastic surgeon-created skincare system may cost double my monthly car payment, but my skin can’t get enough of the potent trio. The good news? It’s on sale for a limited time. Commerce Managing ...

About Monte Rosa Therapeutics Inc. Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, ...